###begin article-title 0
The RhoA transcriptional program in pre-T cells
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 648 652 <span type="species:ncbi:10090">mice</span>
The GTPase RhoA is essential for the development of pre-T cells in the thymus. To investigate the mechanisms used by RhoA to control thymocyte development we have used Affymetrix gene profiling to identify RhoA regulated genes in T cell progenitors. The data show that RhoA plays a specific and essential role in pre-T cells because it is required for the expression of transcription factors of the Egr-1 and AP-1 families that have critical functions in thymocyte development. Loss of RhoA function in T cell progenitors causes a developmental block that pheno-copies the consequence of losing pre-TCR expression in Recombinase gene 2 (Rag2) null mice. Transcriptional profiling reveals both common and unique gene targets for RhoA and the pre-TCR indicating that RhoA participates in the pre-TCR induced transcriptional program but also mediates pre-TCR independent gene transcription.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 461 464 451 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 628 629 618 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 633 634 623 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1043 1048 1017 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3 bib4" ref-type="bibr">[2&#8211;4]</xref>
###xml 1157 1160 1131 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 1296 1297 1270 1271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1300 1301 1274 1275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1514 1515 1477 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1522 1523 1485 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1556 1561 1519 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib7 bib8" ref-type="bibr">[6&#8211;8]</xref>
The T cell antigen receptor (TCR) complex comprises variable alpha/beta subunits that recognise peptide/major histocompatibility (MHC) complexes and invariant signal transduction subunits of the CD3 antigen. A key stage in T cell development in the thymus is the selection of cells that have successfully rearranged their TCR-beta locus. This occurs in T cell precursors, which do not express of the MHC receptors, CD4 and CD8 (double negative (DN) thymocytes) [1]. The DN stages of intrathymic differentiation can be followed by the sequential pattern of expression of CD44 and CD25. T cell progenitors enter the thymus as CD44+CD25- cells (termed DN1); these then express CD25 (DN2) and begin to rearrange T-cell receptor beta loci. Cells then lose CD44 expression and continue beta chain rearrangements to completion (DN3). Cells that successfully rearrange their TCR-beta locus will express a functional receptor complex known as the pre-TCR comprising a TCR-beta chain, the p-Talpha subunit and the signalling subunits of the CD3 antigen [2-4]. When the pre-TCR is expressed at the cell membrane it promotes cell survival and entry into the cell cycle [5]; cells downregulate CD25 and transit to the DN4 pre-T cell subset. DN4 T cells undergo proliferative expansion and differentiate to CD4+CD8+ double positive (DP) cells. These cells then undergo TCR alpha-chain gene rearrangements and upon expression of a functional alpha/beta TCR complex are subjected to positive and negative selection to generate CD4+ or CD8+ single positive (SP) thymocytes [6-8].
###end p 6
###begin p 7
###xml 196 201 196 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib5" ref-type="bibr">[9,5]</xref>
###xml 400 404 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">[10]</xref>
###xml 505 511 498 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11 bib3" ref-type="bibr">[11,3]</xref>
###xml 689 698 682 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib12 bib13" ref-type="bibr">[3,12,13]</xref>
###xml 828 835 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib15 bib16 bib17" ref-type="bibr">[14&#8211;17]</xref>
###xml 203 207 <span type="species:ncbi:10090">Mice</span>
Normal pre-T cell development requires the coordination of a complex program of gene transcription by signal transduction networks mediated by the pre-TCR complex and cytokine and stromal signals [9,5]. Mice deficient for the recombinase activating (RAG) genes which are unable to rearrange TCR-beta subunits and express a pre-TCR are unable to progress beyond the DN3 stage of thymocyte development [10]. Similarly, the absence of pre-Talpha or CD3 subunits blocks thymocyte development at the DN3 stage [11,3]. The transition of thymocytes beyond the pre-T cell stage of thymocyte differentiation is also dependent on signal transduction networks mediated by tyrosine and serine kinases [3,12,13]. In this context, crucial responses are mediated by Rho family guanine nucleotide binding proteins such as RhoA, Rac-1 and CDC42 [14-17].
###end p 7
###begin p 8
###xml 114 135 114 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Clostridium botulinum</italic>
###xml 235 245 235 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib15 bib18" ref-type="bibr">[17,15,18]</xref>
###xml 437 440 437 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lck</italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>Lck</italic></sup>
###xml 521 528 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15 bib17" ref-type="bibr">[15,17]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr">[15]</xref>
###xml 1193 1200 1193 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15 bib19" ref-type="bibr">[15,19]</xref>
###xml 1364 1368 1364 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 1725 1738 1725 1738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib18 bib20 bib21" ref-type="bibr">[10,18,20,21]</xref>
###xml 1801 1805 1801 1805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 85 100 <span type="species:ncbi:10090">transgenic mice</span>
###xml 114 135 <span type="species:ncbi:1491">Clostridium botulinum</span>
###xml 365 380 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 1052 1067 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1358 1362 <span type="species:ncbi:10090">mice</span>
###xml 1430 1434 <span type="species:ncbi:10090">mice</span>
###xml 1551 1555 <span type="species:ncbi:10090">mice</span>
###xml 1647 1651 <span type="species:ncbi:10090">mice</span>
###xml 1655 1659 <span type="species:ncbi:10090">mice</span>
The importance of RhoA for thymocyte development has been demonstrated by studies of transgenic mice that express Clostridium botulinum C3-transferase under the control of T cell specific promoters such as the p56lck and CD2 promoters [17,15,18]. This toxin selectively ADP-ribosylates RhoA within its effector-binding domain and abolishes its biological function. Transgenic mice that express C3-transferase under the control of the p56Lck promoter have a small thymus and severely reduced numbers of peripheral T cells [15,17]. This phenotype is caused by survival defects in DN2 and DN3 thymocytes that lack Rho function [15]. During embryogenesis no cells progress beyond the DN1 stage but in adult mice a few T cell progenitors survive and develop to DN4s and beyond [15]. This 'leakiness' either reflects selection of cells that compensate for loss of Rho function in DN2/3 thymocytes or reflects heterogeneous and asynchronous expression of the lck promoter in adult DN thymocytes. The few DP thymocytes and mature T cells found in adult Lck-C3 transgenic mice have numerous defects including reduced survival, proliferation, integrin mediated cell adhesion and defective cell motility [15,19]. A complementary strategy to probe Rho function in the thymus used the CD2 locus control region (LCR) to target C3 transferase to T cell progenitors (CD2-C3 mice) [18]. The inhibition of Rho function at the DN2/3 stage in CD2-C3 mice is not leaky and causes T cells to become blocked in differentiation at the DN3 stage of thymus development. CD2-C3 mice thus have a thymic phenotype indistinguishable from the phenotype of Recombinase gene null mice or mice lacking key structural or signaling components of preTCR complex [10,18,20,21]: thymocyte development is blocked at the pre-T cell/DN3 stage [18].
###end p 8
###begin p 9
###xml 414 421 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22 bib23 bib24" ref-type="bibr">[22&#8211;24]</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
The basis for the failure of pre-T cell differentiation in CD2-C3 transferase mice is not known. One way to address this issue is to use microarray gene expression profiling to determine the impact of losing Rho function on transcriptional responses in pre-T cells. Previous studies in transformed cell lines have identified a role for RhoA in regulating activating protein-1 (AP1) family of transcription factors [22-24] but transcriptional targets for RhoA signal transduction in primary non-transformed cells have not been explored. The present data show that RhoA regulates expression of genes encoding members of the Fos/Jun and early growth response (Egr) family of transcription factors but also has an impact on expression of genes regulating diverse biological functions including serine/threonine kinases, protein phosphatases, enzymes that regulate protein biosynthesis and proteins that regulate nuclear structure and function.
###end p 9
###begin title 10
Materials and methods
###end title 10
###begin title 11
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 11
###begin p 12
###xml 105 108 105 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 315 308 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib18" ref-type="bibr">[10,18]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 116 131 <span type="species:ncbi:10090">transgenic mice</span>
Mice were bred and maintained under specific pathogen-free conditions in the transgenic animal unit. RAG2-/- and C3 transgenic mice, which selectively express the bacterial toxin C3-transferase under the control of CD2 promoter and locus control region in the thymus, have been described in detail elsewhere [10,18].
###end p 12
###begin title 13
Flow cytometric analysis
###end title 13
###begin p 14
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 527 528 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1447 1453 <span type="species:ncbi:9793">donkey</span>
###xml 1459 1465 <span type="species:ncbi:9986">rabbit</span>
Fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), and biotin-conjugated antibodies were obtained from Pharmingen (San Diego, CA). Tricolour (PE/Cy5 and APC/Alexa750) conjugated antibodies and fluorophore-streptavidin conjugates were from Caltag (Burlingame, CA). Thymocytes were stained for cell surface markers and analysed on a FACS Calibur (Becton Dickinson Immunocytometry Systems Franklin Lakes CA). Data were analysed using CellQuest BDIS or FlowJo (Treestar Inc, Ashland OR) software. CD4-CD8- double negative thymocyte subsets were analysed for CD44 and CD25 expression following lineage exclusion of mature DP and SP cells as well as non-T cell lineage cells using a cocktail of biotinylated antibodies (CD4, CD8, CD3 B220, Mac-1, NK, Gr-1, and gammadelta) revealed with streptavidin-tricolour and costained with CD25-FITC, CD44-PE and Thy1.2-APC. Intracellular phospho-S6 and TCR-beta intracellular staining was carried out on thymocytes pre stained to identify DN3 and DN4 subpopulations. Cells were subsequently fixed in 1% paraformaldehyde for 10 min at room temperature, washed in PBS and permeabilized with saponin buffer (0.5% saponin, 5% FBS, 10 mM HEPES [pH 7.4] in PBS) for 10 min at room temperature. Permeabilized cells were incubated with PE-conjugated TCRbeta antibody and phospho S6 antibody for 45 min at room temperature, washed in saponin buffer and subsequently stained with FITC conjugated donkey anti rabbit IgG (Jackson Immunoresearch, West Grove PA). Cells were analysed on an LSR Flow Cytometer (BDIS).
###end p 14
###begin title 15
RNA extraction
###end title 15
###begin p 16
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 462 463 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 466 467 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 471 472 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 477 478 469 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 483 484 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 846 849 838 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Thymocytes were isolated from 4- to 6-week-old RAG2-/-, CD2-C3 and C57BL/6 control mice. DN3 pre-T cells were purified firstly by removing CD4, CD8 DP cells using MACS CD4+ and -MACS CD8+ T cell isolation kits (Miltenyi Biotec, Ltd.) followed by magnetic autoMACS separation. CD4/CD8 depleted thymocytes were then labelled with Thy1.2-APC, PE conjugated CD4, CD8, CD44 and TCRgammadelta antibodies, FITC conjugated CD25 antibodies and the DN3 subpopulation (Thy1+CD4-/CD8-/CD44-/CD25+) was purified by cell sorting on a FACS Vantage (BDIS) using Cell Quest software (BDIS). All sorted cells were analysed by flow cytometry and only used for experiments if the purity was 95-98%. Total RNA was extracted from sorted cells using the Qiagen RNeasy kit according to manufacturers instructions. Total RNA was quantified using the RNA 6000 Nano LabChip(R) kit and analyzed on an Agilent 2100 Bioanalyzer (Agilent Technologies). Total RNA from up to 10 thymi were pooled for microarray analysis and quantitative PCR.
###end p 16
###begin title 17
Microarray
###end title 17
###begin p 18
###xml 260 263 260 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 1666 1669 1664 1667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 454 <span type="species:ncbi:10090">Mouse</span>
Microarray analysis was carried out by the Finnish DNA Microarray Centre at the Centre for Biotechnology, Turku, Finland. For Affymetrix sample preparation, 100-1000 ng of total RNA was used as the starting material to synthesise target cRNA using the GeneChip(R) Eukaryotic Small Sample Target Labeling Assay Version II according to manufacturers' instructions (Affymetrix, Santa Clara, CA). The cRNA target sample was hybridised to the Affymetrix Mouse Genome 430 2.0 Array (45,101 probes sets and expressed sequence tag (EST) clusters). Data was analysed with Affymetrix Gene Chip Operating Software (GCOS) version 1.1 and filtered according to recommendations of the manufacturer. Comparison analysis was used to compare the expression profiles from two arrays - results were obtained by analyzing the experimental array in comparison to the baseline array. The global method of scaling was used for normalizing hybridization intensity between arrays. The statistical algorithm used by GCOS defined the expression status of each gene-specific probe set as not changed, increased, marginally increased, decreased or marginally decreased. Genes that were absent or unchanged between comparisons were excluded from the results. Comparison analysis defines a gene as up-regulated if the signal log ratio between the baseline sample and the experimental sample is larger than 1 (2-fold) and the experimental sample is present. Similarly changed genes were further analyzed/classified using the gene ontology tool () and represented by biological function. Gene lists were complied and sorted by genes that were either commonly or uniquely regulated in CD2-C3 and RAG2-/- thymocytes.
###end p 18
###begin title 19
Real-time RT-PCR analysis
###end title 19
###begin p 20
###xml 635 636 602 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Purified total RNA (200 ng) was reverse transcribed using the iScripttrade mark cDNA synthesis kit (BioRad). Real time RT-PCR was performed in a 96-well plate using iQtrade mark SYBR Green based detection (BioRad) on a BioRad iCycler in 20 mul reaction volume containing 1 mul cDNA (20 ng), 0.8 mul 10muM sense and antisense primers, 10 mul iQtrade mark SYBR Green supermix, and 4 mul nuclease free water. Each reaction was performed in duplicate and each experiment repeated in triplicate. 18S rRNA levels were used to normalise RNA concentrations between samples and the relative mRNA levels were calculated using the equation:where E is the efficiency of PCR, ct is the threshold cycle, u is the mRNA of interest, r is the reference gene (18S rRNA), s is the sample and c is the control sample. Primers used for RT-PCR were designed using Beacon Designer 2 software. Primer sequences are: Egr1 forward 5'-ACAGAAGGACAAGAAAGCAGAC-3, reverse 5-CCAGGAGAGGAGTAGGAAGTG-3', Fos forward 5'-CTACTGTGTTCCTGGCAATAGC-3', reverse 5'-AACATTGACGCTGAAGGACTAC-3', Egr3 forward 5'-TGACCAACGAGAAGCCCAATC-3', reverse 5'-GCTAATGATGTTGTCCTGGCAC-3', Jun forward 5'-CGCCTCGTTCCTCCAGTC-3' reverse 5'-ACGTGAGAAGGTCCGAGTTC-3', JunB forward 5'-CTTCTACGACGATGCCCTCAAC-3', reverse 5'-GTTCAAGGTCATGCTCTGTTTTAGG-3', Nur77 forward 5'-CCTGTTGCTAGAGTCTGCCTTC-3', reverse 5'-CAATCCAACACCAAAGCCACG-3', 18S RNA forward 5'-GTAACCCGTTGAACCCCATT-3', reverse 5'-CCATCCAATCGTAGTA-3'.
###end p 20
###begin title 21
Results and discussion
###end title 21
###begin p 22
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 257 263 257 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 322 328 322 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 393 400 393 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figs. 1</xref>
###xml 658 664 655 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 903 907 900 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 1197 1204 1194 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib26 bib27" ref-type="bibr">[25&#8211;27]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
Mice expressing the RhoA inhibitor Clostridium Botulinum C3 transferase under the control of the CD2 locus control region (LCR) have been described previously [18]. Loss of RhoA function in CD2-C3 mice results in loss of CD4/CD8 double positive thymocytes (Fig. 1A) with a block in thymocyte development at the DN3 stage (Fig. 1B). Rag2-/- mice also block thymus development at the DN3 stage (Figs. 1A and B) due to failed expression of the pre-TCR complex. Despite this superficial similarity, loss of Rho function does not prevent TCR beta locus rearrangements although there is a reduced frequency of DN3 cells expressing intracellular TCR-beta subunits (Fig. 1C). Ectopic expression of transgenic TCR complexes cannot reverse the developmental block in CD2-C3 thymocytes demonstrating that failed expression of TCR complexes does not explain the developmental defects caused by loss of Rho function [18]. Rho thus appears necessary for pre-TCR function although these results do not discriminate between a direct role for RhoA in pre-TCR signalling or a role for this GTPase in the cytokine/stromal signalling pathways that synergise with pre-TCR signals to control pre-T cell differentiation [25-27].
###end p 22
###begin p 23
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 474 479 <span type="species:ncbi:10090">Mouse</span>
###xml 522 528 <span type="species:ncbi:10090">murine</span>
###xml 635 650 <span type="species:ncbi:10090">transgenic mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
CD2-C3 transferase mice provide a good model system to probe the immediate transcriptional consequences of losing RhoA function in pre-T cells since the CD2-LCR initiates expression of transgenes in T cell progenitors as they transit from the DN2 to DN3 stage of thymocyte development [18]. Accordingly, it is possible to isolate DN3 thymocytes ex vivo that have only just switched on expression of C3 transferase and prepare RNA for DNA microarray analysis. The Affymetrix Mouse Genome 430 2.0 array, representing 39 000 murine gene transcripts, was used to transcriptionally profile DN3 pre-T cells purified from the thymi of CD3-C3 transgenic mice. In these experiments DN3 thymocytes from wild type control mice were transcriptionally profiled and used for comparisons.
###end p 23
###begin p 24
###xml 649 669 649 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
The microarray data were analyzed with the Affymetrix Gene Chip Operating Software (GCOS, version 1.1) by comparing the gene expression profiles of CD2-C3 pre-T cells to the profile of normal cells to reveal changes above or below wild type levels. DN3 pre-T cells expressed approximately 18 000 genes and there were only small changes in the transcriptional profile of CD2-C3 DN3 thymocytes compared to control wild type DN3s. We focused our analysis on ⩾2-fold changes, which were further analyzed using the Affymetrix gene ontology tool. A full list of the genes regulated 2-fold or greater by loss of RhoA function in DN3 thymocytes is shown in Supplementary Fig. 1. There were approximately 18 000 genes expressed in wild type DN3 thymocytes: loss of RhoA function caused a ⩾2-fold decrease in expression of 383 genes and a ⩾2-fold increase in expression of 190 genes. RhoA regulated genes in DN3 thymocytes encode proteins with diverse biological functions including serine/threonine kinases, protein phosphatases, enzymes that regulate protein biosynthesis.
###end p 24
###begin p 25
###xml 29 35 29 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 691 711 691 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 1</xref>
###xml 924 931 924 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28 bib29 bib30" ref-type="bibr">[28&#8211;30]</xref>
This point is illustrated in Fig. 2A, which shows the genes whose expression is regulated more than 10-fold. The largest decrease was in expression of the gene encoding FosL2, a Fos family transcription factor (630-fold decrease) but other large changes included a subunit of eukaryotic translation initiation factor 2, Protein Kinase C beta and the membrane receptor CD69. There was also a loss of expression of genes encoding proteins that regulate nuclear structure and function such as genes encoding histones that are involved in nucleosome assembly. In a similar category there was reduced expression of mRNA encoding special AT-rich sequence binding protein 1 (SATB1) in CD2-C3 DN3s (Supplementary Fig. 1). SATB1 acts as a scaffold for chromatin modifiers and is known to regulate higher order chromatin structure and to regulate gene expression by acting as a "docking site" for several chromatin remodeling enzymes [28-30].
###end p 25
###begin p 26
###xml 149 155 149 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 684 690 684 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 781 786 781 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD2&#8211;C</italic>
Of 55 genes whose expression was decreased ⩾5-fold, 23 encoded transcription factors; of 384 genes decreased ⩾2-fold, 63 were transcription factors (Fig. 2B). Transcription factors downregulated in CD2-C3 DN3 thymocytes included Kruppel family transcription factors KLF4, KLF6 and KLF9. There was also loss of expression of members of the immediate early gene family Egr1 and Egr3, AP-1 family members Fos, FosL2, FosB, Jun, JunB and downregulated expression of genes encoding Ets1 and Nurr77. To validate the microarray analysis, quantitative real-time PCR was used to compare expression of a selection of these different transcription factors in wild type versus CD2-C3 thymocytes (Fig. 2C). The experiments confirmed the reduction in Fos, Jun, JunB, Egr1 and Egr3 and NURR77 in CD2-C3 DN3s compared to wild type controls.
###end p 26
###begin p 27
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr">[31]</xref>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31 bib32 bib33" ref-type="bibr">[31&#8211;33]</xref>
###xml 568 575 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34 bib35 bib36 bib37 bib38" ref-type="bibr">[34&#8211;38]</xref>
###xml 670 673 670 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 679 682 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 896 899 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 906 912 906 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 1082 1085 1082 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1192 1195 1192 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1382 1385 1382 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1392 1398 1392 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1506 1509 1506 1509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1621 1624 1621 1624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1649 1669 1649 1669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 2</xref>
###xml 1725 1728 1725 1728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1875 1878 1875 1878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1937 1940 1937 1940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2065 2068 2065 2068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2076 2082 2076 2082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
A number of gene targets for Egr transcription factors have been described [31] and in this context, RhoA inactivation caused loss of expression of multiple members of the MAP kinase phosphatase family DUSP 1, 2, 4, 6, 16. The latter are induced in negative feedback mechanisms that modulate MAP kinase activity and have been described as targets for Egr family transcription factors [31-33]. The loss of DUSP expression is thus almost certainly a secondary consequence of failed expression of Egr molecules. Egr1 and Egr3 are well characterised pre-TCR induced genes [34-38]. To verify this we compared the transcriptional profile of CD2-C3 DN3s with Recombinase gene 2-/- (RAG2-/-) DN3s which lack expression of the pre-TCR complex because they fail to rearrange their TCR beta locus. Of the 23 transcription factors downregulated ⩾5-fold in CD2-C3 thymocytes 18 were also downregulated in Rag2-/- DN3s (Fig. 2D) and these included Egr1, Egr3, Fos, Fosl2, FosB, Ets1, Nurr77. These microarray analyses were confirmed by quantitative real-time PCR analysis of wild type versus Rag2-/- thymocytes (data not shown). The common loss of expression of members of the Egr family in CD2-C3 and Rag2-/- pre-T cells is thus consistent with a RhoA requirement for the pre-TCR induced gene transcription. However, comparisons of the total number of genes regulated uniquely in CD2-C3 and Rag2-/- DN3s (Fig. 3) (VENN diagrams) indicate that there are a number of gene changes in CD2-C3 cells that are not seen in Rag2-/- DN3s. The full list of genes that were commonly and uniquely regulated 2-fold and greater in CD2 C3 versus Rag2-/- pre-T cells is shown in Supplementary Fig. 2. In terms of ⩾ 2-fold, gene repression, CD2-C3 and Rag2-/- DN3s had 180 gene targets in common with 202 genes being downregulated uniquely in CD2-C3 pre-T cells and 120 genes downregulated uniquely in Rag2-/- cells. In terms of ⩾2-fold gene increases, CD2-C3 and Rag2-/- DN3s had 65 gene targets in common, 129 genes that were increased uniquely in CD2-C3 DN3s and 182 increased uniquely in Rag2-/- cells (Fig. 3).
###end p 27
###begin p 28
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 318 338 318 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 3</xref>
###xml 743 763 743 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 3</xref>
###xml 1018 1025 1018 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39 bib40 bib41 bib42" ref-type="bibr">[39&#8211;42]</xref>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
###xml 1370 1383 1370 1383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43 bib42 bib44 bib45" ref-type="bibr">[43,42,44,45]</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
The common transcriptional changes caused by loss of the pre-TCR in Rag2-/- DN3s or loss of Rho function in CD2-C3 mice indicates that Rho function is necessary for some pre-TCR induced transcriptional responses. However, there are genes downregulated in DN3s lacking RhoA function that are unchanged in Rag2-/- DN3s (Supplementary Fig. 3) indicating that RhoA is not just required to mediate the preTCR induced gene program but may also participate in cytokine/stromal cell-initiated signalling pathways that control pre-T cell differentiation. The genes uniquely lost in CD3-C3 DN3 thymocytes include serine kinases (Protein Kinase C beta and Map3k14); transcription factors (SpiB and Dlx1) and regulators of protein biosynthesis (Eif2s3y) (Supplementary Fig. 3). One gene of interest lost in CD2-C3 DN3s but not Rag2 null DN3s was Hes-1 which is induced by Notch receptor-ligand interactions. Notch signalling is required throughout DN to DP stage of thymocyte development to support T cell metabolism and survival [39-42]. A RhoA requirement for Notch signalling has not been described but it is known that RhoA is necessary for integrin mediated cell adhesion and thymocyte cell migration [19]. Accordingly, decreased Hes-1 expression could reflect that pre-T cells lacking Rho function cannot make normal contacts with stromal cells that express the Notch ligands [43,42,44,45].
###end p 28
###begin p 29
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 109 129 109 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 4</xref>
###xml 265 268 265 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 389 392 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 422 426 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPS6</italic>
###xml 629 632 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 642 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 656 662 650 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 821 824 815 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 876 880 870 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1254 1258 1236 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1320 1323 1299 1302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
There were also unique transcriptional changes seen in Rag2-/- cells that were not found in the CD2-C3 DN3s (Supplementary Fig. 4) which indicates that the pre-TCR can regulate a program of gene transcription via RhoA independent pathways The unique changes in Rag2-/- cells not surprisingly included loss of expression of rearranged TCR-beta subunits. One other gene downregulated in Rag2-/- DN3s but not CD2-C3 DN3s was RPS6, which encodes the ribosomal S6 subunit. In this respect, we recently described high basal levels of S6 phosphorylation in ex vivo beta selected DN3s and no detectable S6 phosphorylation in ex vivo Rag2-/- DN3s [13]. The data in Fig. 4 quantify S6 phosphorylation in CD2-C3 DN3s compared to wild type cells. Normal DN3s are heterogeneous for phosphoS6 with the majority of cells being phosphoS6low but a significant percentage of cells are phosphoS6high. The DN3 thymocyte subpopulation can be subdivided into cells that have not yet completed TCR-beta locus rearrangements and those that express a functional TCR-beta subunit that allows surface expression and signalling of the pre-TCR complex. Analysis of TCRbeta expression by intracellular staining revealed that DN3s that express icTCR-beta chains are generally phosphoS6high whereas DN3s that are icTCR-beta null are uniformly phosphoS6low. In CD2-C3 DN3s there were also high levels of phosphoS6 in TCR-beta high cells. The presence of normal S6 phosphorylation in beta selected DN3s lacking Rho function is a further indication that Rho is necessary for a subset of responses in DN3 thymocytes but does not globally block signalling.
###end p 29
###begin p 30
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 306 283 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app1" ref-type="sec">Supplementary Fig. 4</xref>
###xml 415 418 409 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 793 800 787 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46 bib36" ref-type="bibr">[46,36]</xref>
###xml 1056 1063 1050 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib47 bib48 bib49" ref-type="bibr">[47&#8211;49]</xref>
###xml 1212 1219 1206 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50 bib51" ref-type="bibr">[50,51]</xref>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
One important question is whether the transcriptional changes in CD2-C3 DN3s explain why loss of RhoA function results in failed thymocyte differentiation? In this respect, microarray analysis of Rag2-/- pre-T cells revealed decreased expression of TCR-beta subunits as a major defect (Supplementary Fig. 4) and failed expression of the TCR-beta subunit is indeed responsible for the DN3 developmental block in Rag2-/- mice. In CD2-C3 DN3s there were several gene defects that would explain why RhoA function is essential for pre-T cell development. For example, RhoA is required for expression of Egr3 and Ets1 and loss of either of these transcription factors inhibits pre-T cell proliferation and is suboptimal for transition through early pre-TCR-dependent stages of thymocyte development [46,36]. Loss of individual Egr family or AP-1 transcription factors does not completely abrogate thymocyte differentiation but this reflects that there is considerable redundancy in AP-1 complexes due to the ability of different family members to pair as dimers [47-49]. The simultaneous elimination of Egr1, Egr3, Ets1 and multiple Fos/Jun family members in CD2-C3 DN3s would circumvent the possibility of redundancy [50,51]. This comprehensive loss of AP-1 activity in pre-T cell lacking RhoA function plus the decreased expression of other transcription factors would rapidly cause global changes in the transcriptional program of a cell. Moreover, the transcription factor defects would be exacerbated by the decreased expression of chromatin modifying enzymes such as SATB1.
###end p 30
###begin p 31
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
In summary, loss of Rho function or failed expression of the pre-TCR complex in Rag2-/- null mice block T cell development at a common stage. The present data show that the genetic consequences of loss of Rho function versus loss of pre-TCR expression for T cell progenitors are not identical. The present results also show that loss of Rho function in pre-T cells results in downregulation of genes encoding members of the Fos/Jun and Early growth response (Egr) family of transcription factors. The collective loss of these transcription factors and the resultant secondary genetic changes explains why loss of RhoA function prevents pre-T cell development.
###end p 31
###begin title 32
Supplementary data
###end title 32
###begin p 33
Supplementary data associated with this article can be found, in the online version, at .
###end p 33
###begin title 34
Supplementary data
###end title 34
###begin p 35
###xml 0 22 0 22 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">Supplementary figure 1</title>
###xml 0 22 0 22 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="36">Supplementary figure 1</title></caption>
###xml 22 97 22 97 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">List of total genes downregulated or upregulated in CD2&#8211;C3 DN 3 thymocytes.</p>
###xml 97 97 97 97 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.xls" mimetype="application" mime-subtype="vnd.ms-excel"/>
###xml 0 97 0 97 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c8bfc0N0x2961f50"><caption><title textid="36">Supplementary figure 1</title></caption><p textid="37">List of total genes downregulated or upregulated in CD2&#8211;C3 DN 3 thymocytes.</p><media xlink:href="mmc1.xls" mimetype="application" mime-subtype="vnd.ms-excel"/></supplementary-material>
Supplementary figure 1List of total genes downregulated or upregulated in CD2-C3 DN 3 thymocytes.
###end p 35
###begin title 36
Supplementary figure 1
###end title 36
###begin p 37
List of total genes downregulated or upregulated in CD2-C3 DN 3 thymocytes.
###end p 37
###begin p 38
###xml 0 22 0 22 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">Supplementary figure 2</title>
###xml 0 22 0 22 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="39">Supplementary figure 2</title></caption>
###xml 101 104 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 120 22 120 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">List of genes that are commonly downregulated or upregulated in CD2&#8211;C3 and RAG2<sup>&#8722;/&#8722;</sup> DN3 thymocytes.</p>
###xml 120 120 120 120 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc2.xls" mimetype="application" mime-subtype="vnd.ms-excel"/>
###xml 0 120 0 120 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c8bfc0N0x29620d0"><caption><title textid="39">Supplementary figure 2</title></caption><p textid="40">List of genes that are commonly downregulated or upregulated in CD2&#8211;C3 and RAG2<sup>&#8722;/&#8722;</sup> DN3 thymocytes.</p><media xlink:href="mmc2.xls" mimetype="application" mime-subtype="vnd.ms-excel"/></supplementary-material>
Supplementary figure 2List of genes that are commonly downregulated or upregulated in CD2-C3 and RAG2-/- DN3 thymocytes.
###end p 38
###begin title 39
Supplementary figure 2
###end title 39
###begin p 40
###xml 79 82 79 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
List of genes that are commonly downregulated or upregulated in CD2-C3 and RAG2-/- DN3 thymocytes.
###end p 40
###begin p 41
###xml 0 22 0 22 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Supplementary figure 3</title>
###xml 0 22 0 22 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="42">Supplementary figure 3</title></caption>
###xml 22 93 22 93 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">List of genes that are uniquely downregulated in CD2&#8211;C3 DN3 thymocytes.</p>
###xml 93 93 93 93 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc3.xls" mimetype="application" mime-subtype="vnd.ms-excel"/>
###xml 0 93 0 93 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c8bfc0N0x2962250"><caption><title textid="42">Supplementary figure 3</title></caption><p textid="43">List of genes that are uniquely downregulated in CD2&#8211;C3 DN3 thymocytes.</p><media xlink:href="mmc3.xls" mimetype="application" mime-subtype="vnd.ms-excel"/></supplementary-material>
Supplementary figure 3List of genes that are uniquely downregulated in CD2-C3 DN3 thymocytes.
###end p 41
###begin title 42
Supplementary figure 3
###end title 42
###begin p 43
List of genes that are uniquely downregulated in CD2-C3 DN3 thymocytes.
###end p 43
###begin p 44
###xml 0 22 0 22 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">Supplementary figure 4</title>
###xml 0 22 0 22 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="45">Supplementary figure 4</title></caption>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 108 22 108 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">List of genes that are uniquely downregulated or upregulated in RAG2<sup>&#8722;/&#8722;</sup>DN3 thymocytes.</p>
###xml 108 108 108 108 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc4.xls" mimetype="application" mime-subtype="vnd.ms-excel"/>
###xml 0 108 0 108 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="N0x1c8bfc0N0x29623d0"><caption><title textid="45">Supplementary figure 4</title></caption><p textid="46">List of genes that are uniquely downregulated or upregulated in RAG2<sup>&#8722;/&#8722;</sup>DN3 thymocytes.</p><media xlink:href="mmc4.xls" mimetype="application" mime-subtype="vnd.ms-excel"/></supplementary-material>
Supplementary figure 4List of genes that are uniquely downregulated or upregulated in RAG2-/-DN3 thymocytes.
###end p 44
###begin title 45
Supplementary figure 4
###end title 45
###begin p 46
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
List of genes that are uniquely downregulated or upregulated in RAG2-/-DN3 thymocytes.
###end p 46
###begin title 47
Acknowledgements
###end title 47
###begin p 48
We thank the transgenic animal facility for animal maintenance, Dr Simon Arthur for supplying Real time PCR primers and use of the BioRad iCycler. Members of the Cantrell lab for helpful discussions. This work was supported by a Wellcome Trust Principle Research Fellowship Grant. GR065975. The Academy of Finland, National Technology Agency of Finland and the Turku University Research Fund (R. Lahesmaa).
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Pleiotropic changes controlled by the pre-T-cell receptor
###end article-title 50
###begin article-title 51
The impact of pre-T-cell receptor signals on gene expression in developing T cells
###end article-title 51
###begin article-title 52
Regulation of thymocyte differentiation: pre-TCR signals and beta-selection
###end article-title 52
###begin article-title 53
Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate
###end article-title 53
###begin article-title 54
Regulation of T-cell progenitor survival and cell-cycle entry by the pre-T-cell receptor
###end article-title 54
###begin article-title 55
Signals involved in thymocyte positive and negative selection
###end article-title 55
###begin article-title 56
T-cell development and the CD4-CD8 lineage decision
###end article-title 56
###begin article-title 57
CD4/CD8 coreceptors in thymocyte development, selection, and lineage commitment: analysis of the CD4/CD8 lineage decision
###end article-title 57
###begin article-title 58
A survival guide to early T cell development
###end article-title 58
###begin article-title 59
###xml 16 20 <span type="species:ncbi:10090">mice</span>
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement
###end article-title 59
###begin article-title 60
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Early T-cell development in CD3-deficient mice
###end article-title 60
###begin article-title 61
The role of serine/threonine kinases in T-cell activation
###end article-title 61
###begin article-title 62
Antigen receptor regulation of phosphoinositide-dependent kinase 1 pathways during thymocyte development
###end article-title 62
###begin article-title 63
Expression of activated CDC42 induces T cell apoptosis in thymus and peripheral lymph organs via different pathways
###end article-title 63
###begin article-title 64
Different functions of the GTPase Rho in prothymocytes and late pre-T cells
###end article-title 64
###begin article-title 65
The GTPase Rac-1 controls cell fate in the thymus by diverting thymocytes from positive to negative selection
###end article-title 65
###begin article-title 66
The GTPase Rho has a critical regulatory role in thymus development
###end article-title 66
###begin article-title 67
Inhibition of Rho at different stages of thymocyte development gives different perspectives on Rho function
###end article-title 67
###begin article-title 68
Integrin regulation by RhoA in thymocytes
###end article-title 68
###begin article-title 69
Vav-family proteins in T-cell signalling
###end article-title 69
###begin article-title 70
Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1
###end article-title 70
###begin article-title 71
Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes
###end article-title 71
###begin article-title 72
The small GTP-binding protein RhoA regulates c-jun by a ROCK-JNK signaling axis
###end article-title 72
###begin article-title 73
Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases
###end article-title 73
###begin article-title 74
Cell-fate decisions in early T cell development: regulation by cytokine receptors and the pre-TCR
###end article-title 74
###begin article-title 75
T-cell development made simple
###end article-title 75
###begin article-title 76
Journey through the thymus: stromal guides for T-cell development and selection
###end article-title 76
###begin article-title 77
A thymocyte factor SATB1 suppresses transcription of stably integrated matrix-attachment region-linked reporter genes
###end article-title 77
###begin article-title 78
A nuclear targeting determinant for SATB1, a genome organizer in the T cell lineage
###end article-title 78
###begin article-title 79
Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo
###end article-title 79
###begin article-title 80
An early growth response protein (Egr) 1 cis-element is required for gonadotropin-releasing hormone-induced mitogen-activated protein kinase phosphatase 2 gene expression
###end article-title 80
###begin article-title 81
###xml 54 60 <span type="species:ncbi:10090">murine</span>
The dual specificity phosphatase transcriptome of the murine thymus
###end article-title 81
###begin article-title 82
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
###end article-title 82
###begin article-title 83
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Thymocyte development in early growth response gene 1-deficient mice
###end article-title 83
###begin article-title 84
Early growth response transcription factors are required for development of CD4(-)CD8(-) thymocytes to the CD4(+)CD8(+) stage
###end article-title 84
###begin article-title 85
Early growth response gene 03 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+
###end article-title 85
###begin article-title 86
Egr-2 and Egr-3 are negative regulators of T cell activation
###end article-title 86
###begin article-title 87
Interplay between RORgammat, Egr3, and E proteins controls proliferation in response to pre-TCR signals
###end article-title 87
###begin article-title 88
The bHLH gene Hes1 is essential for expansion of early T cell precursors
###end article-title 88
###begin article-title 89
The bHLH gene Hes1 regulates differentiation of multiple cell types
###end article-title 89
###begin article-title 90
Obligatory role for cooperative signaling by pre-TCR and notch during thymocyte differentiation
###end article-title 90
###begin article-title 91
Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with notch receptor ligation
###end article-title 91
###begin article-title 92
Notch signaling in T cell development
###end article-title 92
###begin article-title 93
The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF
###end article-title 93
###begin article-title 94
Notch ligands delta 1 and jagged1 transmit distinct signals to T-cell precursors
###end article-title 94
###begin article-title 95
The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus
###end article-title 95
###begin article-title 96
Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis
###end article-title 96
###begin article-title 97
The mammalian Jun proteins: redundancy and specificity
###end article-title 97
###begin article-title 98
AP-1 subunits: quarrel and harmony among siblings
###end article-title 98
###begin article-title 99
AP-1 in cell proliferation and survival
###end article-title 99
###begin article-title 100
AP-1 as a regulator of cell life and death
###end article-title 100
###begin p 101
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 217 220 217 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 359 362 359 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 459 460 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 464 465 461 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 470 471 467 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 475 476 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 479 481 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;)</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
Expression of C3 transferase in the thymus of adult mice prevents up regulation of thymocyte developmental markers. (A) Data show flow cytometry analysis of CD4 and CD8 expression on Thy1+ thymocytes from CD2-C3, RAG2-/- and C57BL/6 control mice. (B) Data show flow cytometry analysis of CD25 and CD44 expression on Thy1+ CD4-CD8- thymocytes from CD2-C3, RAG2-/- and C57BL/6 control mice. (C) Histograms show intracellular TCR-beta staining in DN3 cells (CD44-CD25+ Thy1+ CD4-CD8-) from wild type or CD2-C3 transferase mice. Isotype-matched control antibody shows negative staining (dotted line). In 5 experiments, TCR-beta positive cells in wild type DN3s averaged 24% (range 20-25%) whereas in CD2-C3 DN3s averaged 10% (range 7.35-11.47%).
###end p 101
###begin p 102
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Transcriptional changes caused by loss of endogenous RhoA function in DN3 pre-T cells. (A) Table showing the diverse number of genes that display a 10-fold or greater reduction in expression in CD2-C3 DN3 cells compared to wild type DN3 cells. The symbol (-) preceding the numerical value indicates a fold decrease. (B) The table displays total number of transcription factors that display a 2-fold or greater reduction in expression in CD2-C3 DN3 thymocytes compared to wild type DN3 cells. (C) Real time PCR analysis of several transcription factor genes downregulated in CD2-C3 DN3 cells compared to wild type DN3 cells. Error bars indicate the standard deviation obtained from three independent experiments. (D) Table showing comparison of transcription factors downregulated in RAG2-/- DN3 cells with CD2-C3 DN3 cells.
###end p 102
###begin p 103
###xml 242 245 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Differential gene comparison in DN3 pre-T cells lack either endogenous RhoA function or TCR-beta signalling. Venn diagrams showing the number of genes that are uniquely and commonly regulated in CD2-C3 DN3s (lacking RhoA function) versus RAG2-/- DN3s (lacking TCR-beta signalling). The region of overlap regulates genes that are commonly regulated. Gene changes 2-fold and above are shown.
###end p 103
###begin p 104
Endogenous RhoA function is not required for pre-TCR induced phosphorylation of S6. FACS histograms shows intracellular TCR-beta staining profiles (left panel) for wild type and CD2-C3 DN3 cells and subsequent levels of phospho-S6 (right panel) in TCR-beta low or high DN3 cells.
###end p 104

